By: Jason Mast
This story is republished from STAT , the health and medicine news site that's a partner to the Globe. Sign up for STAT's free Morning Rounds newsletter here
Jason Mast is a reporter at STAT focused on the science behind new medicines and the systems that determine their accessibility to patients. His reporting covers a range of topics within medicine and healthcare, including pharmaceuticals, gene therapy, and oncology. Jason has been featured in several prominent publications, including Endpoints News, RamaOnHealthcare, STAT News, and The Boston Globe.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jason Mast's primary focus is on healthcare, pharmaceuticals, and scientific advancements in the field. His articles tend to cite data and press releases heavily, indicating a preference for fact-based reporting.
When reaching out to Jason, consider offering insights from experts in the fields of CRISPR technology, gene therapy, pharmaceuticals industry trends, or specific diseases being discussed. Additionally, he may be interested in government announcements related to healthcare policies or regulations impacting these areas.
As there is no specified geographic focus for Jason's coverage area; therefore global perspectives on relevant topics would likely be appreciated.
This information evolves through artificial intelligence and human feedback. Improve this profile .